Analysis-Corona Remedies IPO

PROs:

• High annual growth of 16.7% CAGR

• One of the fastest growing Pharma company of India

• Diversified portfolio of 71 brands.

• Very good distribution network

• lean Balance sheet

• Improved profitability

• Strong investor demand

CONs:

• Major revenue generation from 3 areas- Woman healthcare,Pain management and Cardio

• 96% revenue from Indian market only

• Negative market sentiment